Navigation Links
KV Pharmaceutical to File Form 12b-25 on November 12, 2008
Date:11/10/2008

ST. LOUIS, Nov. 10 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) announced today that due to the ongoing Audit Committee inquiry previously announced, the Company will be delayed in the filing of its Form 10-Q for the second quarter of fiscal 2009. The Company expects to file a Form 12b-25 Notice of Late Filing with the Securities and Exchange Commission on Wednesday, November 12, 2008.

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The company markets its technology-distinguished products through ETHEX Corporation, a national leader in pharmaceuticals that compete with branded products, and Ther-Rx Corporation, its branded drug subsidiary.

For further information about KV Pharmaceutical Company, please visit the Company's corporate website at http://www.kvpharmaceutical.com.

Safe Harbor

The information in this release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning KV's operations, future results and prospects. Such statements may be identified by the use of words like "plans", "expect", "aim"," believe", "projects", "anticipates", "commit", "intend", "estimate", "will", "should", "could" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, all statements pertaining to the expected filing date of the Company's Form 12b-25 with the Securities and Exchange Commission and the release of its press release pertaining to the quarter's results, and all statements pertai
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...Discovery could aid in development of simple scree... 1 (HealthDay News) -- In a finding that could lea..., U.S. researchers have identified immune system m...ople at high risk for lung cancer. , The resear...amples from 137 people with non-small cell lung c...
(Date:12/1/2009)...Could identify those who would benefit from liver ...UESDAY, Dec. 1 (HealthDay News) -- A CT scan of li...er may help predict overall survival after chemoth... (Avastin) to cytotoxic chemotherapy has been show...colorectal cancer and to produce better results in...
(Date:12/1/2009)...CDC urges H1N1 vaccination because pandemic,s cour...c. 1 (HealthDay News) -- A U.S. health official sa...o be on the wane nationally, but many experts agre...er. , The flu is now widespread in 32 states --.... Frieden, director of the U.S. Centers for Diseas...
(Date:12/1/2009)... , MIAMI, FL (December 1, 2009)The Clinical Resea...ler School of Medicine, has been honored for its s... the LEED designation, established by the U.S. Gre...ding Certification Institute (GBCI). LEED is the n...ction and operation of green buildings., "Having ...
(Date:12/1/2009)... Ever thought you could q...n! Kevin Arthur Smith,s groundbreaking new system ...ly, permanent. In just twenty eight days your crav.... , (PRWEB) December 1, 2...during her eight-year addiction to nicotine, smoki...
Breaking Medicine News(10 mins):Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3
...hnson &,Johnson will participate in the 28th Annua...ay, March 20th at the Boston Marriott Copley Place...Worldwide Chairman,Consumer Group will represent t... the Johnson & Johnson website at http://www.inve...
...h 13 Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS...ief Executive Officer and President, will provide ...erences in March., -- Mr. Swisher will speak at ...ace in Boston, Mass. -- On Thursday, March 20, 20...
...Compliance with Upcoming Federal Mandates, PORTLA...of next generation healthcare connectivity solutio...C) has selected Kryptiq,s eScriptMessenger(TM),(eS...rom within GE,s Centricity EMR directly to retail ...
...PRNewswire-FirstCall/ - Neurochem,(International) ...Neurochem,Inc. (NASDAQ: NRMX ; TSX: NRM), announc...ursue the drug development program for its investi...o build,upon its eprodisate (KIACTA(TM)) asset and...
...-by-Minute and Trend Information That Can ...BOTT PARK, Ill., March 13 The Food and Drug,Admin...or(R) Continuous,Glucose Monitoring System ( http:... sensor in the back of the upper arm or,abdomen,( ...
... light on environmental questions facing the minin...nding (MOU) signed today at the GLOBE 2008 confere...RARCO Mining Innovation. , MIRARCO prides itself ...doubtedly be of tremendous benefit, not only to us...
Other Medicine News:Health News:Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution 2Health News:Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution 3Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 2Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 3Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 4Health News:FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System 2Health News:FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System 3Health News:FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System 4Health News:FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System 5Health News:MIRARCO, Canadian Light Source agreement lights way to greener mining 2
(Date:12/1/2009)..., SCHAUMBURG, Ill., Dec. 1 Sage...ty pharmaceutical company, today announced the lau...SP and ceftriaxone for injection, USP. Both are an...ivity against gram-positive and gram-negative bact...l in December to complement the four vial sizes la...
(Date:12/1/2009)... , REDWOOD CITY, Calif., Dec. 1 /PRNewswire/ ...ts relationship and the signing of its second agre...s Ltd., the world,s largest generic drug manufactu...harmaceutical products. Codexis announced an earl...the new agreement, Teva will use Codexis biocataly...
(Date:12/1/2009)... , NEW YORK, Dec. 1 ...changing market dynamics for an industry experienc...hcare reforms are likely to drive up the effectiv...ces industry, according to a report released toda... Taxing times ahead - Which path will you take? T...
Breaking Medicine Technology:Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2Codexis Expands Collaboration with Teva 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5Star Scientific Files Second Quarter Financial Results 3B Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and V 54097 1Star Scientific Files Second Quarter Financial Results 3B Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and V 54097 2Star Scientific Files Second Quarter Financial Results 3B Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and V 54097 3Star Scientific Files Second Quarter Financial Results 3B Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and V 54097 4Star Scientific Files Second Quarter Financial Results 3B Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and V 54097 5El En Group Establishes New Subsidiary DEKA Medical Inc and Appoints Management Team 54092 1El En Group Establishes New Subsidiary DEKA Medical Inc and Appoints Management Team 54092 2PLUS Diagnostics Announces Senior Executive Appointments 54089 1PLUS Diagnostics Announces Senior Executive Appointments 54089 2PLUS Diagnostics Announces Senior Executive Appointments 54089 3
...ponding to President Obama,s call for "a cure for ...nd Manufacturers of America (PhRMA) delivered a ne...ne for cancer. The report shows that America,s pha...re testing a record 861 new cancer medicines and v...ing tested in human clinical trials or are awaitin...
...h 31 PharmAthene, Inc. (NYSE Amex: PIP ), a biod...against biological and chemical threats, announced...tim(R) were presented at the Keystone Symposia on ...itic Cells, March 29-April 3, 2009 in Banff, Alber...Cross, Professor of Medicine and Dr. Subhendu Basu...
Other Medicine Technology:New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 2New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 3New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 4Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 2Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 3Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 4Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 5Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 6
RoamAlert Eco
AgileTrac™ Patient Flow
...(RFID) helps incorporate people and intelligent ob...alue chain. The power of RFID is that it can help ...es in support of strategy. From patient wristbands...rs tremendous potential to improve asset visibilit...
Radianse Indoor Positioning Patient Location
Medicine Products: